ArticleFrontiers in surgery2025
Characteristics and treatment strategies of the hip fracture triad.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Staged treatment of osteonecrosis of the femoral head induced by delayed treatment of polytrauma complicated by chronic acetabular fracture and hip dislocation: a case report.Frontiers in surgery · 2026Article
- Serum VEGF and ANGPT1 as angiogenesis markers may predict the outcomes of older adults with hip fractures.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To explore the clinical characteristics and treatment strategies of the hip fracture triad (acetabular fracture, hip dislocation combined with proximal femur fracture). Methods: A retrospective analysis was performed on 11 patients with hip fracture triad admitted to Shandong Provincial Hospital from January 2014 to December 2020. There were 9 males and 2 females; age (38.7 ± 12.2) years old (range 12-53 years). After all patients are admitted to the hospital, a treatment plan will be formulated based on the fracture type and associated injuries, and long-term follow-up will be conducted. Results: This study included clinical data of 11 patients with hip fracture triad, of which 9 cases were treated surgically and 2 cases were treated conservatively. All patients were followed up. 9 patients successfully completed the operation. The operation time was (4.4 ± 1.4) hours (range 3-8 h); intraoperative bleeding was (600.0 ± 355.9) ml (range 400-1,200 ml). Fracture reduction was evaluated according to the acetabular fracture Matta score: 7 cases were excellent, 2 was good, and none was poor; 2 patients with old injuries chose conservative treatment as the final treatment plan. Acetabular fractures at the final follow-up were evaluated using the modified Merle d'Aubigné-Postel score of the hip joint: 7 cases were excellent, 1 was good, and 3 were poor. 1 patient developed traumatic hip arthritis after surgery, underwent total hip arthroplasty, and recovered well after surgery; 1 patient underwent hemihip arthroplasty 1 year after surgery due to femoral neck fracture and recovered well after surgery; 1 patient suffered from cerebral infarction complicated by long-term bed rest, poor hip joint mobility and basic loss of self-care ability; 2 patients with conservative treatment of old fracture had limited hip joint functional mobility, unequal length of both lower limbs, and poor hip joint mobility. Conclusion: The hip fracture triad is a complex, high-energy injury that is extremely rare clinically. A correct understanding of the characteristics and mechanism of this type of injury, and prompt and effective treatment strategies, will help improve patient prognosis. Surgery is the preferred treatment option for this injury, and early reduction or lower limb traction can help reduce the occurrence of postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.